BUENOS AIRES, ARGENTINA – 20 de noviembre de 2017 – En el día de la fecha, el Instituto de Vacunas Sabin (Sabin) reunió a periodistas de toda América Latina con el fin de ayudarlos a entender la ciencia de las vacunas.
Statements and Press Releases
BUENOS AIRES, ARGENTINA – Today, the Sabin Vaccine Institute (Sabin) convened journalists from across Latin America to contribute to their understanding of the science of vaccines.
DUBAI, UNITED ARAB EMIRATES – October 22, 2017 – Today, the Sabin Vaccine Institute (Sabin) convened public health leaders from across the Middle East and North Africa for a two-day interactive workshop to share experiences and strategies in strengthening adolescent health and immunization.
WASHINGTON, D.C. – The Sabin Vaccine Institute (Sabin) is pleased to announce the election of Wendy Commins Holman to its Board of Trustees. Ms. Holman is the CEO and founder of Ridgeback Biotherapeutics, a biotechnology company focused on developing treatments and diagnostics for underserved patient populations primarily in pediatric orphan and emerging infectious diseases.